Clinical trial

A Multiple Dose Study of LY3209590 in Participants With Type 2 Diabetes

NCT06169982

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-12-07

PhasePHASE1

Study timeline

Study start (actual)2023-12-07Date precision: day

Registry last updated2024-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

LY3209590DRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06169982 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.